Audacia to host webinar on 2026 half-year results
Bitget2026/10/08 11:32Audacia scheduled a live webinar on its 2026 half-year results for Oct. 14, 2026, at 6:00 p.m. Chairman Charles Beigbeder and CEO Olivier de Panafieu will present first-half highlights and group outlook. A live Q&A session will follow; registration link: https://app.livestorm.co/newcap-1/audacia-presentation-des-resultats-semestriels-2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Audacia SA published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.
- Audacia scheduled a live webinar on its 2026 half-year results for Oct. 14, 2026, at 6:00 p.m.
- Chairman Charles Beigbeder and CEO Olivier de Panafieu will present first-half highlights and group outlook.
- A live Q&A session will follow; registration link: https://app.livestorm.co/newcap-1/audacia-presentation-des-resultats-semestriels-2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
